Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

TBPH Theravance Biopharma, Inc.
$20.31 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TBPH stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 1.0B
Enterprise value 749.6M
Trailing PE 35.824562
Forward PE 12.08284
PEG Ratio -0.28225412484848
Enterprise to EBITDA -24.055
Enterprise to revenue 9.332
Price to book MRQ 4.446864
Price to sales TTM 12.881485

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 80.3M
EBITDA -31164000
Diluted EPS TTM 0.57
Total Cash (MRQ) 329.7M
Current ratio (MRQ) 9.482
Operating Cash Flow (TTM) 243.7M

TBPH trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent TBPH News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.